27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Atossa Therapeutics (NASDAQ:ATOS) shares are trading higher on Thursday after Ascendiant Capital initiated coverage on the stock with a Buy rating and a price target of $7 per share.
Atossa Therapeutics is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
Atossa Therapeutics shares were up 9.78% at $2.47 at the time of publication on Thursday. The stock has a 52-week high of $5.08 and a 52-week low of 76 cents.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!